Scarica l'app Stockscreener
8.48
3.31%
-0.29
Dopo l'orario di chiusura:
8.33
-0.15
-1.77%
Precedente Chiudi:
$8.77
Aprire:
$8.78
Volume 24 ore:
1.23M
Relative Volume:
0.90
Capitalizzazione di mercato:
$753.06M
Reddito:
$73.48M
Utile/perdita netta:
$-108.30M
Rapporto P/E:
-3.7689
EPS:
-2.25
Flusso di cassa netto:
$-67.17M
1 W Prestazione:
-13.65%
1M Prestazione:
+12.92%
6M Prestazione:
+41.10%
1 anno Prestazione:
+121.99%
Intervallo 1D:
$8.415
$8.925
Intervallo di 1 settimana:
$8.415
$9.848
Portata 52W:
$2.8262
$11.40
Personalis Inc Stock (PSNL) Company Profile
Nome
Personalis Inc
Settore
Industria
Telefono
650-752-1300
Indirizzo
6600 DUMBARTON CIRCLE, FREMONT, CA
Confronta PSNL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
8.48 | 778.81M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
575.91 | 215.01B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
228.53 | 159.87B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
700.13 | 56.23B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
140.60 | 39.54B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
223.63 | 37.85B | 15.90B | 1.28B | 2.21B | 7.2842 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-15 | Iniziato | Guggenheim | Buy |
| 2025-03-17 | Iniziato | Craig Hallum | Buy |
| 2023-02-06 | Aggiornamento | Needham | Hold → Buy |
| 2022-01-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Downgrade | Needham | Buy → Hold |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-20 | Reiterato | Needham | Buy |
| 2021-05-06 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-12 | Reiterato | Needham | Buy |
| 2020-11-06 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-08-27 | Iniziato | H.C. Wainwright | Buy |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Iniziato | BofA/Merrill | Neutral |
| 2019-07-15 | Iniziato | Cowen | Outperform |
| 2019-07-15 | Iniziato | Morgan Stanley | Overweight |
| 2019-07-15 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Personalis Inc Borsa (PSNL) Ultime notizie
Personalis (NASDAQ:PSNL) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer - Business Wire
What AI ML Trends Might Elevate Afcons Infrastructure Limiteds Stock ProspectsDividend Yield Trends & Free Dynamic Investment Techniques - earlytimes.in
Why Analysts See Personalis Story Shifting With Medicare Tailwinds And Biopharma Headwinds - Yahoo Finance
Personalis, Inc. $PSNL Shares Purchased by Blue Water Life Science Advisors LP - MarketBeat
Personalis, Inc. (NASDAQ:PSNL) Stocks Shoot Up 38% But Its P/S Still Looks Reasonable - 富途牛牛
Personalis (NASDAQ:PSNL) Stock Price Down 4.8%What's Next? - MarketBeat
Personalis Outpaces The Market With Cancer Test Breakthroughs - Finimize
Personalis (NASDAQ:PSNL) Cut to Sell at Wall Street Zen - MarketBeat
Is Personalis Inc. (04X) stock undervalued by metricsEarnings Miss & Short-Term High Return Strategies - Newser
Geode Capital Management LLC Buys 851,422 Shares of Personalis, Inc. $PSNL - MarketBeat
Will Personalis Inc. (04X) stock maintain strong growthWeekly Volume Report & Growth Focused Investment Plans - Newser
Will Personalis Inc. (04X) stock beat Nasdaq index returns2025 Short Interest & Real-Time Volume Spike Alerts - Newser
Will Personalis Inc. (04X) stock outperform Dow JonesMarket Risk Summary & Fast Moving Market Watchlists - Newser
How Personalis Inc. stock performs during Fed tightening cycles2025 Growth vs Value & Weekly Chart Analysis and Trade Guides - Newser
Will Personalis Inc. stock reach Wall Street targetsInsider Selling & Free Expert Verified Stock Movement Alerts - Newser
Personalis (PSNL) Rating Maintained and Price Target Raised by M - GuruFocus
Personalis (NASDAQ:PSNL) Shares Gap Down After Insider Selling - MarketBeat
Personalis, Inc. (NASDAQ:PSNL) Q2 2025 Earnings Call Transcript - MSN
Morgan Stanley Raises Price Target on Personalis to $11 From $9, Keeps Equalweight Rating - marketscreener.com
Piper Sandler Healthcare Conference - MarketScreener
Personalis, Inc. (NASDAQ:PSNL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Personalis Announces $100M Stock Offering Amendment - The Globe and Mail
Insider Selling: Personalis (NASDAQ:PSNL) CFO Sells 103,668 Shares of Stock - MarketBeat
Personalis files prospectus supplement for up to $100 million stock offering - Investing.com Nigeria
Personalis files prospectus supplement for up to $100 million stock offering By Investing.com - Investing.com South Africa
Personalis, Inc. Announces $100 Million Stock Offering - TradingView
Personalis CFO and COO Aaron Tachibana Sells Over 100K Shares - TradingView
COO Tachibana Sells 103,668 ($1.1M) Of Personalis Inc [PSNL] - TradingView
Insiders Of Personalis Make A Tidy Sum Selling At US$7.14 - simplywall.st
Personalis Stock: A Growth Inflection Is Imminent (NASDAQ:PSNL) - Seeking Alpha
Personalis (NASDAQ:PSNL) Hits New 12-Month HighHere's What Happened - MarketBeat
Personalis Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
COO Tachibana Files To Sell 103,668 Of Personalis Inc [PSNL] - TradingView
Personalis says CMS revises reimbursement rate for Personal test for post-treatment surveillance of cancers - marketscreener.com
Personalis Says CMS Revises Reimbursement Rate For Personal Test For Post-Treatment Surveillance Of Cancers - TradingView
Personalis receives updated Medicare reimbursement rates for cancer monitoring tests - Investing.com India
Personalis, Inc. Announces Revised Medicare Reimbursement Rates - TradingView
[8-K] Personalis, Inc. Reports Material Event | PSNL SEC FilingForm 8-K - Stock Titan
How Analyst Views Are Shifting as Personalis Transforms Its Growth Story - Yahoo Finance
Personalis Inc buy BiotechBee - sharewise.com
BTIG Maintains Personalis (PSNL) Buy Recommendation - MSN
Connor Clark & Lunn Investment Management Ltd. Purchases Shares of 68,679 Personalis, Inc. $PSNL - MarketBeat
Will Personalis Inc. stock recover faster than marketWeekly Profit Report & Fast Moving Market Watchlists - newser.com
Why retail investors favor Personalis Inc. stockJuly 2025 WrapUp & Fast Gain Swing Alerts - newser.com
Can Personalis Inc. stock resist market sell offsLong Setup & Free Technical Confirmation Trade Alerts - newser.com
Will Personalis Inc. (04X) stock benefit from Fed rate cuts2025 Market Sentiment & Daily Market Momentum Tracking - newser.com
Personalis Inc Azioni (PSNL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Personalis Inc Azioni (PSNL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tachibana Aaron | CFO AND COO |
Nov 25 '25 |
Sale |
10.78 |
103,668 |
1,117,541 |
164,458 |
0.04%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):